Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, will host a conference call and webcast on ...
At exactly 2 p.m. last Thursday, I dialed a number somewhere in southeastern Massachusetts, entered a six-digit event code on my cell phone, and joined a conference call from my home office with a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results